Literature DB >> 19345098

VE-Cadherin-mediated cell-cell interaction suppresses sprouting via signaling to MLC2 phosphorylation.

Sabu Abraham1, Margaret Yeo, Mercedes Montero-Balaguer, Hugh Paterson, Elisabetta Dejana, Christopher J Marshall, Georgia Mavria.   

Abstract

During new blood vessel formation, the cessation of angiogenic sprouting is necessary for the generation of functional vasculature. How sprouting is halted is not known, but it is contemporaneous with the development of stable intercellular junctions [1]. We report that VE-cadherin, which is responsible for endothelial adherens junction organization [2, 3], plays a crucial role in the cessation of sprouting. Abrogating VE-cadherin function in an organotypic angiogenesis assay and in zebrafish embryos stimulates sprouting. We show that VE-cadherin signals to Rho-kinase-dependent myosin light-chain 2 phosphorylation, leading to actomyosin contractility [4], which regulates the distribution of VE-cadherin at cell-cell junctions. VE-cadherin antagonizes VEGFR2 signaling, and consequently, inhibition of VE-cadherin, Rho-kinase, or actomyosin contractility leads to VEGF-driven, Rac1-dependent sprouting. These findings suggest a novel mechanism by which cell-cell adhesion suppresses Rac1-dependent migration and sprouting by increasing actomyosin contractility at cell junctions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19345098     DOI: 10.1016/j.cub.2009.02.057

Source DB:  PubMed          Journal:  Curr Biol        ISSN: 0960-9822            Impact factor:   10.834


  66 in total

1.  Evolution of the VEGF-regulated vascular network from a neural guidance system.

Authors:  Sreenivasan Ponnambalam; Mario Alberghina
Journal:  Mol Neurobiol       Date:  2011-01-28       Impact factor: 5.590

2.  A novel microtubule-modulating agent EM011 inhibits angiogenesis by repressing the HIF-1α axis and disrupting cell polarity and migration.

Authors:  Prasanthi Karna; Padmashree C G Rida; Ravi Chakra Turaga; Jinmin Gao; Meenakshi Gupta; Andreas Fritz; Erica Werner; Clayton Yates; Jun Zhou; Ritu Aneja
Journal:  Carcinogenesis       Date:  2012-06-07       Impact factor: 4.944

Review 3.  PAK1 as a therapeutic target.

Authors:  Julia V Kichina; Anna Goc; Belal Al-Husein; Payaningal R Somanath; Eugene S Kandel
Journal:  Expert Opin Ther Targets       Date:  2010-07       Impact factor: 6.902

4.  Phosphorylation of VE-cadherin controls endothelial phenotypes via p120-catenin coupling and Rac1 activation.

Authors:  Kunihiko Hatanaka; Michael Simons; Masahiro Murakami
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-10-29       Impact factor: 4.733

5.  Cardenolide-rich fraction of Pergularia tomentosa as a novel Antiangiogenic agent mainly targeting endothelial cell migration.

Authors:  Mahya Hosseini; Mahdi Ayyari; Anna Meyfour; Sonia Piacente; Antonietta Cerulli; Alexander Crawford; Sara Pahlavan
Journal:  Daru       Date:  2020-07-01       Impact factor: 3.117

Review 6.  Dissecting cell adhesion architecture using advanced imaging techniques.

Authors:  Penny E Morton; Maddy Parsons
Journal:  Cell Adh Migr       Date:  2011-07-01       Impact factor: 3.405

7.  Anchorage of VEGF to the extracellular matrix conveys differential signaling responses to endothelial cells.

Authors:  Tom T Chen; Alfonso Luque; Sunyoung Lee; Sean M Anderson; Tatiana Segura; M Luisa Iruela-Arispe
Journal:  J Cell Biol       Date:  2010-02-22       Impact factor: 10.539

8.  Endothelial-Rac1 is not required for tumor angiogenesis unless alphavbeta3-integrin is absent.

Authors:  Gabriela D'Amico; Stephen D Robinson; Mitchel Germain; Louise E Reynolds; Gareth J Thomas; George Elia; Garry Saunders; Marcus Fruttiger; Victor Tybulewicz; Georgia Mavria; Kairbaan M Hodivala-Dilke
Journal:  PLoS One       Date:  2010-03-22       Impact factor: 3.240

Review 9.  Keeping in touch with contact inhibition of locomotion.

Authors:  Roberto Mayor; Carlos Carmona-Fontaine
Journal:  Trends Cell Biol       Date:  2010-06       Impact factor: 20.808

10.  Human blood vessel-derived endothelial progenitors for endothelialization of small diameter vascular prosthesis.

Authors:  Amaresh K Ranjan; Umesh Kumar; Ashutosh A Hardikar; Pankaj Poddar; Prabha D Nair; Anandwardhan A Hardikar
Journal:  PLoS One       Date:  2009-11-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.